Mind Matters Natural and Artificial Intelligence News and Analysis

TagMatt Scholz

young-sample-plant-growing-in-test-tube-biotechnology-research-concept-stockpack-adobe-stock
young sample plant growing in test tube , biotechnology research concept

What Biotech Innovations Can Help Us Live Longer, Healthier?

Jay Richards interviews venture capitalist Matt McIlwain, whose firm invests in new tech on current promising new directions

At COSM 2021, business prof Jay Richards interviewed venture capitalist Matt McIlwain, CEO of the Madrona Group, which invests in a wide range of promising software applications: McIlwain chaired a panel on innovations in biotech, “Killing Disease and Living Longer” on November 11, 2021: Matt Mcilwain (Moderator) — Managing Director, Madrona Venture GroupStephen C. Meyer — Director, Center for Science and CultureJim Tour — T.t. and W.f. Chao Professor of Chemistry, Rice UniversityMatthew Scholz — CEO, Oisin Biotechnologies Casey Luskin offers an account of McIlwain’s 2021 panel at “Manipulating molecules: Combining info + nano for better medicine”: Yesterday at COSM 2021, philosopher of science Stephen Meyer, synthetic organic chemist James Tour, and biotech entrepreneur Matthew Scholz looked at how nanotechnology…

seattle-skyline-at-sunset-with-space-needle-stockpack-adobe-stock
Seattle Skyline at Sunset with Space needle

Venture Capital Manager at COSM 2021 to Listen and Learn

The Managing Director of Seattle-based Madrona Venture Group will moderate two panels on new technologies that can shake things up

In 2019, Madrona’s Matt McIlwain moderated a panel at the COSM 2019 Technology Summit, “AI’s Role in Unlocking Human Potential.” The panel followed tech pioneer and prophet Ray Kurzweil’s livestreamed address in which he predicted that we will merge with our computers by 2045 — The Singularity: “Our intelligence will then be a combination of our biological and non-biological intelligence,” he explained. We will be apps of our smart computers. Or will we? And if that happened, would it be progress? Already, we freak out when we can’t find our phones, or our computers crash, or the internet is down. Or the power goes off. Yet Isaac Newton changed physics with a pen and paper. So did Albert Einstein. McIlwain…

genetic-engineering-and-gene-manipulation-concept-hand-is-replacing-part-of-a-dna-molecule-stockpack-adobe-stock.jpg
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule.

Gene Therapy: IT Meets Medicine, But Who Is In Charge?

A biotechnology CEO would like to see patients have more power in determining advanced treatments

Jay Richards talked recently with Matt Scholz, Founder & CEO of Oisín Biotechnologies, about the challenges and promises of the information theory of biotech, especially as related to medicine: The panel in which Scholz participated at COSM 2019 focused on how artificial intelligence can make a difference in medicine: From the interview: Jay Richards: So how would you distill this panel? It was you and Babak Parviz, formerly of Google Glass and now from Amazon (and formerly Google Glass) and Lindy Fishburne, who’s on the funding side of information technology and biology. Matt Scholz: The panel was put together ranging from the computational side of it to the actual therapeutic side and finance. So I think that made it a…

Composite image of interface

Google Glass Inventor to Speak at COSM, October 25

Babak Parviz, now an Amazon vice-president, is keenly interested in services for the swelling aged population worldwide
Joining Parviz on the panel will be Matt Scholz, CEO of Oisin Technologies (researching treatments for age-related diseases), George Gilder, philosopher of technology, and Lindy Fishburne, executive director of Breakout Labs, which funds innovative science ventures. Read More ›